NeurologyLive® Mind Moments®

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we spoke with Matthew B. Harms, MD, associate professor of neurology, Columbia University, and medical consultant and care center director, Muscular Dystrophy Association. In honor of May as ALS Awareness Month, he detailed the impact that awareness efforts have had on improving patient care and some of the latest research and advances that have been made in amyotrophic lateral sclerosis.Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Elyse Stock, MD, chief medical officer, Biohaven Pharmaceuticals, and Thomas Shiovitz, MD, director of California Neuroscience Research, to discuss the recently initiated phase 2/3 clinical trial of zavegepant, an oral CGRP-targeting agent for the prevention of migraine developed by Biohaven, as well as how the treatment fits into the gepant class, and the impact that the gepants have had on migraine care overall. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Stephanie J. Nahas, MD; Bruce Cree, MD, PhD, MAS; Sana Somani, MD, MBBS; Hubert Fernandez, MD; Daniel Ontaneda, MD, PhD; and Richard Gershon, PhD. Each of them discussed data that they respectively presented at the American Academy of Neurology Annual Meeting. These presentations included novel tools for tracking cognitive decline, analyses of subpopulations of patients with migraine treated with new medicines, the disparities faced by women and Black individuals going through stroke rehabilitation, and more. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. Check out NeurologyLive's complete coverage of the 2021 American Academy of Neurology Annual Meeting here: neurologylive.com/aan REFERENCES 1. Nahas S, Ning X, Cohen JM, Barash S, Campos VR, Silberstein SD. Efficacy of fremanezumab in patients with moderate and higher frequency episodic migraine. Presented at 2021 American Academy of Neurology Annual Meeting. Abstract P10.046 2. Nahas S, Jurgens TP, Kessler Y, et al. Cardiovascular safety of fremanezumab in patients with migraine and cardiovascular medical history or risk factors: A pooled analysis of phase 3 studies. Presented at 2021 American Academy of Neurology Annual Meeting. Abstract P10.034 3. Cree B, Bennett J, Weinshenker B, et al. Long-term efficacy outcomes with inebilizumab treatment in NMOSD: the N-MOmentum trial. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P15.076 4. Cree B, Bennett J, Weinshenker B, et al. Long-term safety outcomes with inebilizumab treatment in NMOSD: the N-MOmentum trial. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P15.100 5. Somani S, Nanavati H, Xiaohua Z, Lin C. African American women have lower functional performance during acute inpatient rehabilitation after intracerebral hemorrhagic strokes. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P5 073 6. Fernandez H, Odin P, Standaert D, et al. Identifying gaps in Parkinson disease patients eligible for device-aided therapies: results from using the MANAGE-PD tool in patients from G7 countries. Abstract P14.117 7. Ontaneda D, Qu J, McGinley M, et al. A Data Driven Approach to Define Disease Course Categories in MS. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P15.244 8. Pila S, Novak M, Weintraub S, et al. The Mobile Toolbox (MBT): A Completely Remote Platform for Cognitive Research. Presented at 2021 American Academy of Neurology Annual Meeting; April 17-22. Abstract P7.086

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Daniel Claassen, MD, MS, director, Huntington’s Disease Clinic, and division chief, Behavioral and Cognitive Neurology, Vanderbilt University Medical Center. He discussed the recent news of trial program terminations from Roche and Wave Life Science and the hope that remains in the Huntington disease pipeline despite these setbacks. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Bhooma Aravamuthan, MD, DPhil, assistant professor of pediatric neurology, Department of Neurology, Washington University in St Louis, who recently completed a survey of child neurologists and neurodevelopmentalists regarding their inclusion in the diagnosis of individuals with cerebral palsy, about the findings and the current status of care for the condition. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCE Aravamuthan BR, Shevell M, Kim YM, et al. Role of child neurologists and neurodevelopmentalists in the diagnosis of cerebral palsy. Neurology. 2020;95(21):962-972. doi: 10.1212/WNL.0000000000011036.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Brian Grosberg, MD, director, Hartford Headache Center, and professor of neurology, University of Connecticut School of Medicine, about the results of a recently published study he and colleagues conducted that assessed the knowledge of women’s healthcare providers such as OB/GYNs in the management of migraine in their patients—a patient population that is mostly women. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCE Verhaak AMS, Williamson A, Johnson A, et al. Migraine diagnosis and treatment: A knowledge and needs assessment of women’s healthcare providers. Headache. 2021;61(1):69-79. doi: 10.1111/head.14027.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we spoke with Stewart Factor, DO, professor of neurology, and director, Jean and Paul Amos Parkinson’s Disease and Movement Disorders Program, Emory University School of Medicine, to discuss the swinging pendulum that is the therapeutic pipeline for Parkinson disease and some of the obstacles that stand in the way of providing optimal care to patients.Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Jennifer Martin, PhD, professor of medicine, University of California-Los Angeles, and a board member of the American Academy of Sleep Medicine (AASM), to discuss the AASM's recent clinical practice guideline update that recommends the use of multi-component cognitive behavioral therapy for the treatment of insomnia. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCE Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. Published online November 9, 2020. doi: 10.5664/jcsm.8986

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with M. Scott Perry, MD, co-director, Jane and John Justin Neurosciences Center, Cook Children’s Hospital; Orrin Devinksy, MD, director, Comprehensive Epilepsy Center, NYU Langone; and Tracy Salazar, PhD, executive director, LGS Foundation. The discussion centered around this week, the inaugural Seizure Action Plan (SAP) Awareness Week, February 8 to 15, 2021, an initiative to raise awareness about the importance of developing SAPs for patients with epilepsy and their caregivers. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we feature a portion of our NeurologyLive Cure Connections series, “Multiple Sclerosis Patient Journey,” put on in partnership with the Consortium of Multiple Sclerosis Centers (CMSC). It features a diverse panel of people including Patricia K. Coyle, MD, an expert neurologist; Frederick Foley, PhD, a clinical psychologist; Ann Moore, a patient with MS; and her partner, Kathe Zelles. Moderated by June Halper, MSN, MSCN, the group shares their perspectives and experiences on various facets of the disease.You can check out the entire series here: neurologylive.com/MS-patient-journey Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Jacqueline French, MD, director, Translational Research and Clinical Trials in Epilepsy, NYU Grossman School of Medicine. She discussed recently published data from part of the Human Epilepsy Project that suggests the delay in identifying nonvoter seizures can result in injury for the individuals experiencing them, and that earlier identification may prevent this issue. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.REFERENCEPellinen J, Tafuro E, Yang A, et al. Focal nonmotor versus motor seizures: The impact on diagnostic delay in focal epilepsy. Epilepsia. 2020;61(12):2643-2652. doi: 10.1111/epi.16707

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Leigh Charvet, PhD, clinical neuropsychologist, Division of MS, NYU Langone Health. She spoke to the work she and colleagues have done in validating and assessing digital therapeutics and telemedicine approaches in MS, and how these interventions might make an impact on the invisible symptoms of the disease. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Jennifer Frontera, MD, neuro-intensivist, NYU Langone Health, who we spoke with during the early days of the pandemic. This time, she discussed the complications in determining the cause of death with COVID-19, the need for continued social distancing and mask-wearing, the impact the pandemic has had on her mental health, and her silver linings in spite of these challenges. In that same light, we reached out to a number of physicians across neurology specialties to find out what their silver linings have been for their clinical practice despite the immense adversity that this year has brought. They are, in order of appearance: Alireza Atri, MD, PhD Jacqueline French, MD Jessica Ailani, MD Rajesh Pahwa, MD Darin Okuda, MD Sabrina Paganoni, MD, PhD Raman Malhotra, MD Dileep Yavagal, MD Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Lon Schneider, MD, MS, Della Martin Chair in Psychiatry and Neuroscience, University of Southern California Keck School of Medicine; Marwan Sabbagh, MD, director, Lou Ruvo Center for Brain Health, Cleveland Clinic; Stephen Salloway, MD, MS, director, Neurology and the Memory and Aging Program, Butler Hospital; Richard S. Isaacson, MD, director, Alzheimer’s Prevention Clinic, Weill Cornell Medicine; and Anton Porsteinsson, MD, director, Alzheimer's Disease Care, Research, and Education Program, University of Rochester.Each of these experts provided their perspective and insight into what’s been happening in the conversations around aducanumab and why there is some controversy around its clinical trial data, as well as how all of this speaks to the intricacies and difficulties in actually conducting clinical trials in Alzheimer disease.Part 1 – Support, Skepticism, and Statistics: The Aducanumab Saga Part 2 – Compounding Challenges: Conducting Clinical Trials in Alzheimer Disease Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Merle Diamond, MD, president and managing director, Diamond Headache Clinic, in Chicago, Illinois. She discussed her real-world experience with the newest additions to the acute migraine treatment paradigm, and what impact they’ve had on clinical practice. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Paul Fisher, MD, professor of neurology, and chief of child neurology, and Gerald Grant, MD, FACS, endowed professor of neurosurgery, and chief of pediatric neurosurgery, both of the Brain and Behavior Center at Stanford Children’s Health. The pair discussed how their team at the center is bolstering multidisciplinary care and harnessing advances in science to improve the care of children with neurologic disease and more. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we're joined by Indu Subramanian, MD, director of the VA Southwest Parkinson’s Disease Research, Education, and Clinical Centers. She discussed the findings and implications of a recent study she conducted which suggests that loneliness and social isolation can actually be a predictor of disease worsening in Parkinson disease. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.REFERENCESubramanian I, Mischley L, Farahnik J. Loneliness/Social Isolation as a Risk Factor for Worsened Parkinson Disease Severity. Presented at MDS Virtual Congress; September 12–16, 2020.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Raman Malhotra, MD, associate professor of neurology, Washington University in St. Louis, and board of directors, American Academy of Sleep Medicine. He detailed some of the advances in therapy and research in sleep medicine and highlighted some of the challenges faced by sleep specialists. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Costantino Iadecola, MD, Anne Titzell Professor of Neurology, and director and chair, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine. He discussed the shortcomings of the current clinical approach to Alzheimer disease and offered insight into how vascular risk factors play a role in its pathology. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by David Vossler, MD, professor, and medical director, The Neuroscience Institute, UW Medicine Valley Medical Center. He discussed the findings of a recently published phase 3 dataset on lacosamide, also known as Vimpat, and its effects on reducing genetic generalized onset tonic-clonic seizures. Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. This episode is the first part of a 3-part multimedia series from NeurologyLive on the metamorphosis of migraine care. In this episode, we're joined by Stewart Tepper, MD, director of research, Dartmouth Headache Clinic, and professor of neurology, Dartmouth Giesel School of Medicine. He offers insight into how migraine care has evolved since the 1990s thanks to a number of scientific discoveries and the therapeutic developments that followed. Thanks for listening to the NeurologyLive Mind Moments podcast. For more neurology news and expert-driven content, visit neurologylive.com. This is part 1 of a special 3-part multimedia series. For part 2, "Evidence and Epidemiology," click here.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Rajesh Pahwa, MD, the Laverne and Joyce Rider Professor of Neurology; chief of the Parkinson’s and Movement Disorder Division; and director of the Parkinson's Foundation Center for Excellence at the University of Kansas Medical Center. He offers insight into the challenges of medication adherence in Parkinson disease and how it impacts OFF episode management. Thanks for listening to the NeurologyLive Mind Moments podcast. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Richard Finkel, MD, a pediatric neurologist and recently named head of the new Center for Experimental Neurotherapeutics at St. Jude Children’s Research Hospital. Finkel offered an in-depth look at how the recent FDA approval of oral risdiplam (Evrysdi; Roche) might impact the spinal muscular atrophy (SMA) therapeutic landscape.Thanks for listening to the NeurologyLive Mind Moments podcast. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Dr. Jeffrey Cummings, the director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and the vice-chair of the Department of Brain Health at the University of Nevada–Las Vegas. Dr. Cummings shared his insight into a recent review he and colleagues did of the trends in the Alzheimer Disease pipeline.Thanks for listening to the NeurologyLive Mind Moments podcast. For more neurology news and expert-driven content, visit neurologylive.com

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we’re joined by Dr. Daniel Claassen, an associate professor of neurology in the Department of Cognitive and Behavioral Neurology and Movement Disorders at Vanderbilt University. Dr. Claassen discussed the recent work he and colleagues did in assessing the feasibility of conducting clinical trials using therapies that target single nucleotide polymorphisms, or SNPs, in patients with Huntington disease. Thanks for listening to the NeurologyLive Mind Moments podcast. For more neurology news and expert-driven content, visit neurologylive.com.REFERENCEClaassen DO, Corey-Bloom J, Dorsey ER, et al. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. Neurology. 2020;6(3):e430. doi: 10.1212/NXG.0000000000000430

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Dr. Bryan Davis, a clinical health psychology fellow at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic. Dr. Davis spoke to what he took away from a recent undertaking by him and colleagues exploring the impact of gender norms and masculinity on men with multiple sclerosis. For more neurology news and expert-driven content, visit neurologylive.com.

Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we're joined by Dr. Shadi Yaghi, an associate professor in the Department of Neurology at NYU Grossman School of Medicine and the Director of Clinical Vascular Neurology Research at NYU Langone Health and of Vascular Neurology at NYU Langone Hospital-Brooklyn. Dr. Yaghi offers his perspective on a recent study he and colleagues conducted of patients with stroke and COVID-19 and the difficulties in understanding their relationship. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCE Yaghi, S, Koto I, Torres J, et al. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51:00–00. doi: 10.1161/STROKEAHA.120.030335

Welcome to the NeurologyLive Mind Moments podcast. In this episode, we're joined by Jennifer Frontera, MD, professor of neurology at NYU Langone Grossman School of Medicine, and a neurocritical care specialist, who shares her experience working on the frontline during the COVID-19 pandemic in providing care for patients with the virus who have preexisting neurologic conditions. She details her firsthand experience with COVID-19 in a hospital setting, as well as what neurologic symptoms have been observed in these patients. For more neurology news and expert insight, head to NeurologyLive.com.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, we're joined by Fernando Pagan, MD, vice chairman of the department of neurology, and director of the Movement Disorder Program and National Parkinsonism Foundation Center of Excellence at Georgetown University Hospital. He discussed the current state of science in the treatment of Parkinson disease with a focus on the management of OFF episodes, as well as the impact that the COVID-19 pandemic has had on patient care. For more neurology news and expert insight, head to NeurologyLive.com.

Welcome to the NeurologyLive Mind Moments podcast. This special episode of the Mind Moments Podcast is focused on the ongoing COVID-19 pandemic. The spread of the novel virus has resulted in an upheaval of daily life both inside and outside of the clinic. We are learning more everyday about the risks for patients with neurological disorders, especially those who receive treatment with therapies that act on the immune system, and the significant adjustments required to keep clinical care running smoothly during this time. In this episode, Barry Singer, MD, Director of the MS Center for Innovations in Care at Missouri Baptist Medical Center in St. Louis, discusses how he is actively making adjustments to his patients' treatment regimens to help reduce their risk in the face of the novel coronavirus. Our second guest, Nina Riggins, MD, PhD, a headache specialist at the University of California in San Francisco, has taken her practice online via telemedicine in response to the spread of COVID-19. Riggins offers her insights on the transition to telemedicine visits, as well as specific treatment considerations for patients with headache disorders. For more on MS, headache, and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Daniel M. Hartung, PharmD, MPH, associate professor of pharmacy at Oregon State University College of Pharmacy, discusses findings of a report he and colleagues compiled on rising spending in the US Medicaid program on disease-modifying therapies for multiple sclerosis, and the unique nature of their prices in the United States. For more on MS and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Donald Frei, MD, a neurointerventional surgeon at Swedish Medical Center and Radiology Imaging Associates in Denver, Colorado, and past president of the Society for Neurointerventional Surgery, discusses efforts to improve stroke systems of care, starting with advocating for changes to national legislation on EMS triage and transport protocols. For more on stroke and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco, shares the latest research updates showing how the gut microbiome plays a role in epilepsy, and how altering the gut microbiota may prove to be a very promising therapeutic option in the future. For more on epilepsy and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Amaal Starling, MD, assistant professor of neurology at Mayo Clinic Scottsdale, shares her experiences with a number of new migraine drugs and devices and the impact that more options will have on clinical practice.For more on migraine and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Fred Rincon, MD, MSc, Chief of cerebrovascular disease at the Farber Institute for Neuroscience and associate professor of neurology and neurological surgery at Thomas Jefferson University in Philadelphia, reflects on the current state of vascular neurology and how technology can play a major role in closing the gaps in stroke care. For more on stroke and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Reisa Sperling, MD, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital and Massachusetts General Hospital, and Professor of Neurology at Harvard Medical School, shares her thoughts on the amyloid hypothesis, and discusses the future of Alzheimer disease research focused on early detection and intervention. For more on Alzheimer disease, dementia, and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. In this episode, Anup Patel, MD, Section Chief of Pediatric Neurology at Nationwide Children’s and Associate Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine, discusses the current state of cannabidiol (CBD) in the US, and why increasing public access to the molecule via legalized marijuana is becoming a big problem for clinicians treating patients with serious neurologic disorders. For more on CBD, epilepsy, and other neurology topics, visit NeurologyLive.com. Thanks for listening.